Source:http://linkedlifedata.com/resource/pubmed/id/11401879
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2001-6-12
|
pubmed:abstractText |
To study local lung inflammation, 34 subjects had endotoxin (1-4 ng/kg) instilled into a lung segment and saline instilled into a contralateral segment followed by bronchoalveolar lavage (BAL) at 2 h, 6 h, 24 h, or 48 h. Endotoxin instillation resulted in a focal inflammatory response with a distinct time course. An early phase (2 h to 6 h) revealed an increase in neutrophils (p = 0.0001) with elevated cytokines (tumor necrosis factor [TNF]-alpha, TNF receptors [TNFR], interleukin [IL]-1beta, IL-1 receptor antagonist, IL-6, granulocyte-colony-stimulating factor [G-CSF], all p < or = 0.002, but no change in IL-10) and chemokines (IL-8, epithelial neutrophil activating protein-78, monocyte chemotactic protein-1, macrophage inflammatory protein [MIP]-1alpha, MIP-1beta, all p < or = 0.001, but no change in growth-regulated peptide-alpha). A later phase (24 h to 48 h) showed increased neutrophils, macrophages, monocytes, and lymphocytes (all p < or = 0.02), and a return to basal levels of most mediators. Elevated levels of inflammatory markers (TNFR(1), TNFR(2), L-selectin, lactoferrin, and myeloperoxidase) persisted in the BAL at 48 h (p < or = 0.001). Increased permeability to albumin occurred throughout both phases (p = 0.001). Blood C-reactive protein, serum amyloid A, IL-6, IL-1ra, G-CSF, but not TNF-alpha increased by 8 h (all p < or = 0.008). The local pulmonary inflammatory response to endotoxin has a unique qualitative and temporal profile of inflammation compared with previous reports of intravenous endotoxin challenges. This model provides a means to investigate factors that initiate, amplify, and resolve local lung inflammation.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1073-449X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
163
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1591-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11401879-Adult,
pubmed-meshheading:11401879-Bronchoalveolar Lavage Fluid,
pubmed-meshheading:11401879-Bronchoscopy,
pubmed-meshheading:11401879-Chemokines,
pubmed-meshheading:11401879-Cytokines,
pubmed-meshheading:11401879-Endotoxins,
pubmed-meshheading:11401879-Escherichia coli,
pubmed-meshheading:11401879-Female,
pubmed-meshheading:11401879-Humans,
pubmed-meshheading:11401879-Inflammation,
pubmed-meshheading:11401879-Inflammation Mediators,
pubmed-meshheading:11401879-Instillation, Drug,
pubmed-meshheading:11401879-Lung,
pubmed-meshheading:11401879-Male,
pubmed-meshheading:11401879-Neutrophils,
pubmed-meshheading:11401879-Pilot Projects
|
pubmed:year |
2001
|
pubmed:articleTitle |
Local inflammatory responses following bronchial endotoxin instillation in humans.
|
pubmed:affiliation |
Critical Care Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|